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S
enthil Muthuswamy has traveled 
far from the small town in southern 
India where he grew up: all the 
way to ground zero in the fi  ght against 
cancer. His work is laying a path toward 
a new understanding of the role of cell 
polarity in tumorigenesis (1, 2).
Senthil’s journey to his new stomp-
ing grounds started at an agricultural 
school in India. It took him through his 
PhD with William Muller at McMaster 
University in Hamilton, Canada, studying 
the role of the receptor tyrosine kinase 
ErbB2 in breast cancer (3). He next took 
a postdoctoral position with Michael 
Gilman at ARAID Pharmaceuticals (4). 
At ARAID, Senthil met Joan Brugge and 
soon started a postdoc with her, moving 
to Harvard Medical School where he de-
veloped a three-dimensional cell culture 
system that would launch 
the rest of his career (5).
Today, Muthuswamy 
is happy with where he 
fi   nds himself, directing re-
search programs at two 
laboratory groups—one at 
Cold Spring Harbor Labo-
ratory, New York, and an-
other at the Ontario Cancer 
Institute in Toronto, Can-
ada, where he has recently moved. 
We tracked him down at his Canadian 
offi  ce to talk about the ground he’s covered 
so far, and what he sees on the road ahead.
CAMPUS LIFE
Where did you grow up?
I was born in the southern part of India, in 
a small town called Rasipuram. My father 
was a professor, a soil chemist, at agricul-
tural research stations in Tamil Nadu, a 
state in southern India.
Was that your inspiration for pursuing 
a career in science?
It’s not very common in America or Can-
ada, but in India, the universities provide 
on-campus housing for professors, so my 
family actually lived on the campus where 
my dad worked. He would take me into 
his laboratory a lot, so I really grew up 
around science. As a kid, I always wanted 
to do something related to science, but I 
was particularly interested in medicine, in 
part because I was inspired by one of my 
uncles, who is a pediatrician.
Also I should say that in India 
when I was growing up, there was this 
sort of mantra taught to all the kids that 
you had to aim for a professional col-
lege in engineering, medicine, or agri-
culture. Nowadays of course everyone 
wants to do computer science. But back 
then if you didn’t do well in your sec-
ondary school exams and make it into 
one of these professional schools, then 
you were no longer going to be successful 
in your life.
And where did you end up?
As it turned out, I went to an 
agricultural school called 
Tamil Nadu Agricultural 
University. I was very keen 
on genetics, so after my un-
dergraduate studies there, I 
went on to an advanced in-
stitute in New Delhi to do a 
master’s thesis. I studied the 
genetics of cooking qualities in different 
basmati rice strains!
JUMP ACROSS THE POND
Studying rice is very different from what 
you’re working on now! How did that 
come about?
Yes, from there to breast cancer was a big 
jump! I eventually decided to switch to 
mammalian biology because, although I 
liked plants, I was interested in the mo-
lecular aspects of things—genetics, 
molecular and cell biology, and so on. At 
the time, these approaches were far more 
advanced in mammalian systems than in 
plants. Also, government funding for 
research was not great in India, so there 
was no incentive to do in-depth science. 
Things are changing now and there is a 
great deal of importance given to basic 
research, but back then everything was 
focused on applied research.
I started applying to a lot of gradu-
ate programs, and the one at McMaster 
University was attractive because it 
came with a Canadian International 
Development Agency scholarship that 
provided full funding, including a travel 
allowance. Coming from India, where 
I was planning to support myself, that 
was a huge boost. So I said, “Okay, I’m 
going there.”
Was that a big transition for you?
Oh, absolutely. To start with, the weather 
was freezing in Canada compared with 
India, and there were mountains of snow. 
That was a huge shock. And also cultur-
ally… I felt intimidated by the openness 
of the society. In India, you’re not sup-
posed to openly disagree with people be-
cause it’s not polite. Here you are sup-
posed to disagree with your mentor or 
professor if there is a need for it. That 
was surprising, and it took a while to ad-
just, but I eventually adapted. I tell my 
students and postdoctoral fellows now, 
that they should never hesitate to raise 
questions and have a healthy debate. It is 
a great way to learn.
Senthil Muthuswamy uses 3D cell culture to explore the influence of cell 
polarity on oncogenic transformation.
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“Cancer is 
a disease 
of tissue 
structure and 
shape, not 
just of cells.”
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What about your scientiﬁ  c adaptations?
I didn’t know anything about mammalian 
biology, so I had to learn the basics. I took 
all the standard courses: biochemistry and 
molecular cell biology. I also took pathol-
ogy. The pathology classes were an eye-
opening experience, because they imme-
diately taught me that cancer is a disease 
of tissue structure and shape, not just of 
cells. This meshed with my research at 
the time: In the Muller laboratory every-
one was making mouse models for breast 
cancer. We’d take different oncogenes 
and express them in a mammary gland and 
see what kind of tumors you’d get. We knew 
that those oncogenes seemed to do very 
similar things when you transform cells 
in tissue culture, yet each oncogene gave 
rise to a different histopathologically dis-
tinct tumor. Nobody understood why.
MIND THE GAP
The distinct effects of oncogenes really 
seemed to capture you.
When I went to Joan Brugge’s laboratory 
to do my postdoctoral work, we looked at 
ways to study why these different onco-
genes create distinct kinds of tumors in ani-
mals. We were inspired by Mina Bissell’s 
work on three-dimensional cell culture and 
decided to study cancer and transformation 
in a 3D context. Joan and Mina started 
collaborating, and I did a few experiments 
using ErbB2 and other molecules that I 
had been studying in my PhD. We found 
that when we put different oncogenes—
for example, EGF receptor, cyclin D1, or 
ErbB2—into cells and grew the cells on a 
fl  at plastic dish, you couldn’t tell them 
apart by looking at them. But, we would 
see completely different and obvious 
phenotypes when the cells were grown in 
3D culture. While we already knew the 
role of uncontrolled proliferation 
in cancer, this system clearly told 
us that there is also something else 
going on.
And what is that something else?
Well, this is a diffi  cult  problem, 
and one I took with me to my own 
laboratory at Cold Spring Harbor 
Laboratory. We had lots of ideas 
about it that didn’t really pan out. 
Our fi  rst big insight came when we 
started looking at the impact of 
some of these oncogenes on cell polarity. 
We found that active ErbB2 not only 
provokes cell proliferation, but also disrupts 
apical–basal polarity when it is overex-
pressed in epithelia. But, the pathways 
by which ErbB2 infl  uences cell polarity 
and proliferation are entirely separable. 
That led us to ask: What is the effect of 
simply disrupting polarity pathways? We 
investigated a polarity protein called 
Scribble and found that when cell polar-
ity is defective, you get disorganized 
growth, but not overproliferation, in 3D 
culture. However, when you combine 
Scribble defects with a proliferation driv-
er—for example, oncogenes like c-myc 
or human papillomavirus 
E7—you get an ErbB2-
like situation.
This observation required 
an eye for detail.
I like to look at the details, 
maybe because of my hob-
by, photography. I get in-
spired by looking at things. 
In photography and in cell 
biology, the important stuff 
is all in the details and what 
perspective you take to look 
at a given situation.
Do you think this might be a common 
progression in cancer?
Yes. If you think about it, cells divide a lot 
in response to physiological conditions and 
cues. For example, remodeling colonic 
epithelium or expanding ductal epithelium 
in the breast are tissues with high cell 
proliferation  rates. However, as long as 
cell–cell interactions are being recognized 
and the cell polarity machinery is intact, 
cells are able to form a restricted pattern 
of 3D structural morphogenesis to main-
tain tissue organization.
Cells can sense the mechanical 
tensions that tell them they’ve grown 
enough and should stop growing. But 
if a cell is unable to normally polarize 
and organize its growth, it is no longer 
constrained by these signals because 
it’s not sensing them. So, any sort of 
genetic or epigenetic event that inter-
feres with genes and pathways that reg-
ulate polarization and morphogenesis 
will lead to a loss of tissue structure. 
The way we see it, this creates a per-
missive environment for 
other events to happen 
that push a cell into un-
controlled proliferation 
and unorganized growth. 
Loss of tissue organiza-
tion is a recipe for disas-
ter in the long run.
We’re very excited 
because these ideas al-
low us to think about the 
cancer cell in a different 
way, one that will allow 
us to fi  nd ways to treat 
cancer early.
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Human mammary epithelial cells grown in 3D 
culture (left) form structures resembling breast 
tissue (right).
“In cell biology, 
the important 
stuff is all in 
the details 
and what 
perspective 
you take to 
look at a given 
situation.”
Muthuswamy’s photo, “Summer Ice.”